Remove 2023 Remove Healthcare Remove Pharma
article thumbnail

Pharma firepower, M&A surge last year bode well for dealmaking prospects in 2024: EY

Fierce Pharma

Morgan Healthcare Conference. | The late surge of activity in 2023 also bodes well for a 2024 uptick, the group said. Biopharma companies looking to maximize the visibility of their M&A activity often reveal deals during the J.P.

article thumbnail

JPM24: Pfizer CEO promises 'year of execution' after recent struggles, Seagen buyout

Fierce Pharma

Pfizer knows it had a bad year in 2023. Pfizer knows it had a bad year in 2023. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches. Speaking to reporters at the 2024 J.P.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CPHI Pharma Awards 2023 finalists announced

European Pharmaceutical Review

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. Award winners will be revealed at a networking reception on the first day of CPHI Barcelona 2023, which is running from 24-26 October. Are you coming to the CPHI Barcelona 2023?

Pharma 119
article thumbnail

FDA committee set to discuss strain selection for next round of COVID-19 boosters

Fierce Pharma

While demand for COVID-19 vaccines has plummeted throughout 2023, healthcare officials remain focused on ensuring that the most effective shots are available for those who need them.

article thumbnail

Our predictions for Pharma in 2023

Impetus Digital

The growing role of artificial intelligence (AI) and the importance of the “human aspect” throughout Pharma operations. After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) in person again, believing that’s what most KOLs want.

Pharma 95
article thumbnail

JP Morgan 2023 – Day 2

pharmaphorum

Fierce’s event “The long haul: How pharma and healthcare can survive in 2023” will feature guests from Bayer, Takeda, Genentech, and more. The post JP Morgan 2023 – Day 2 appeared first on. We’ll do our best to surf between the two, as well as providing remote updates where we can from the main event.

article thumbnail

JP Morgan 2023 – Pre event

pharmaphorum

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday. The post JP Morgan 2023 – Pre event appeared first on. We’ll also wander over to the UC Davis Health Future & Health CEO Summit a little later this afternoon.

Pharma 122